Premium
Acumen Pharmaceuticals Inc (ABOS)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Return on Assets (%) | -209.943 | -28.309 | -73.232 | -20.077 | -20.671 |
| Return on Equity (%) | 134.606 | 48.815 | -97.396 | -20.705 | -22.982 |
| Return on Invested Capital (%) | -267.478 | -36.047 | -16.911 | -24.697 | -30.069 |
| Operating Margin (%) | -465.94 | -510.097 | N/A | N/A | N/A |
| Net Profit Margin (%) | -452.917 | -510.097 | N/A | N/A | N/A |
| Book Value Per Share | 14.272 | 90.84 | 4.663 | 2.726 | 3.099 |
| Earnings Per Share | -18.344 | -17.482 | -2.083 | -0.619 | -0.608 |
| Cash Per Share | 15.637 | 104.48 | 2.53 | 1.879 | 0.776 |
| Working Capital Per Share | 13.928 | 90.84 | 4.007 | 2.491 | 2.712 |
| Operating Profit Per Share | 4.05 | 3.427 | N/A | N/A | N/A |
| EBIT Per Share | -18.871 | -17.482 | -2.083 | -0.619 | -0.608 |
| EBITDA Per Share | -18.871 | -17.482 | -2.083 | -0.619 | -0.608 |
| Free Cash Flow Per Share | -18.344 | -17.482 | -2.083 | -0.617 | -0.608 |
| Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
| Actions en circulation | 419k | 419k | 20,06M | 41,03M | N/A |
| Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
|---|---|---|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
| Actions en circulation | 41,03M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capitalisation boursière | 73,3M |
| Ratio cours/bénéfice | -1,43 |
| Ratio prix/ventes | 0 |
| Ratio prix/liquidités | 1,12 |
| Ratio prix/valeur comptable | 0,28 |
| Rendement de dividende | - |
| Actions en circulation | 60,08M |
| Volume moyen (1 semaine) | 150,57k |
| Volume moyen (1 mois) | 196,05k |
| Variation sur 52 semaines | -70,63% |
| Plus haut sur 52 semaines | 4,43 |
| Plus bas sur 52 semaines | 1,10 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
